tiprankstipranks
Neurocrine (NBIX)
NASDAQ:NBIX

Neurocrine (NBIX) Stock News & Sentiment

1,178 Followers
Neurocrine presents data from CAHtalyst Pediatric Phase 3 clinical study
PremiumThe Fly
Neurocrine presents data from CAHtalyst Pediatric Phase 3 clinical study
5d ago
Neurocrine price target raised to $150 from $140 at Citi
PremiumThe Fly
Neurocrine price target raised to $150 from $140 at Citi
6d ago
Neurocrine price target raised to $164 from $154 at Canaccord
PremiumThe Fly
Neurocrine price target raised to $164 from $154 at Canaccord
6d ago
Neurocrine price target raised to $216 from $200 at Oppenheimer
PremiumThe Fly
Neurocrine price target raised to $216 from $200 at Oppenheimer
6d ago
Neurocrine price target raised to $169 from $150 at Barclays
PremiumThe Fly
Neurocrine price target raised to $169 from $150 at Barclays
6d ago
Neurocrine price target raised to $170 from $164 at Guggenheim
PremiumThe Fly
Neurocrine price target raised to $170 from $164 at Guggenheim
7d ago
Neurocrine price target raised to $160 from $150 at H.C. Wainwright
PremiumThe Fly
Neurocrine price target raised to $160 from $150 at H.C. Wainwright
7d ago
More NBIX News >

News Score - Last 7 Days

Neutral
NBIX
Sector Average
Media Buzz
This Week4 articles
Weekly Average5.5 articles
News Sentiment
This Week50%
Sector Average65%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NBIX’s Media Buzz Sentiment?
4 articles about NBIX were published this week. In an average week, 5.5 articles are published.
    What is NBIX’s weekly average amount of articles?
    In an average week, 5.5 articles about NBIX are published.
      What is NBIX’s News Sentiment?
      50% of articles about NBIX were positive this week, compared to its sector average of 65%.
        Healthcare Stocks that are Trending in the News
        SLPSimulations Plus
        LGNDLigand Pharma
        AVTBFAvant Brands
        ANSLFAnsell
        PHGEBiomX
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis